uvstocks.io

Today’s CSR movers

ETR 4.0 ▲ 1.5

SO 3.0 ▲ 1.0

NTAP 3.6 ▲ 0.5

PWR 4.6 ▲ 0.5

SNPS 4.6 ▲ 0.5

APA 3.1 ▲ 0.1

ITW 2.7 ▲ 0.1

CF 2.9 ▼ 0.1

VMC 3.7 ▼ 0.1

COO 3.6 ▼ 0.1

Health Care · NYSE NYSE · CRL

Charles River Laboratories

$278.26 +$5.37 +1.93% CLOSE 09.11.26 AFTER HOURS $278.26

Convergence score

4.0 / 5.0 STRONG BULLISH

+0.0 vs last report

Overall valuation

Overvalued

Aggregated across multiple horizons

Consensus target (12mo)

$275.90 -0.8%

Range $145.00 — $320.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 09.11.26

UV Convergence Score

REPORT 09.11.26

4.0

/ 5.0

STRONG BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Analyst average

4.2

Multi-signal aggregate How CSR works →

Day Range

$275.63 – $280.40

52W Range

$144.26 – $303.31

Volume

767.6K

Avg Vol

895.9K

Mkt Cap

$13.28B

P/E

—

EPS (TTM)

—

Div Yield

—

Beta

1.41

Today's convergence

Convergence score sits at 4.0 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Overvalued

CSR direction

STRONG BULLISH

Last close

$278.26

Sector

Health Care

Valuation

Three horizons

UPDATED 09.11.26

Short term

0–3 MO

No target —

Medium term

3–12 MO

$266-4.5% Buy

Long term

12–36 MO

$206.55-25.8% Overvalued

Open valuation →

Analysts

Coverage & consensus

3 PANELS

Mean target (12mo)

$275.90 -0.8%

RANGE $145.00 — $320.00

Analyst consensus

Consensus rating Buy

Blended score 4.1 / 5

Analysts tracked 45

Open analysts →

Financials

Key metrics

LATEST

P/E

—

EPS (TTM)

—

Mkt Cap

$13.28B

Div Yield

—

Beta

1.41

52W Range

$144.26 – $303.31

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26

Short term

0–3 MO

—

Consensus target

No target available

Medium term

3–12 MO

Buy

Consensus target

$266 -4.5%

RANGE $175 – $320

$175NOW $278.26$320

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Overvalued

Consensus target

$206.55 -25.8%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: -	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $468.86M	PB Ratio: -	PS Ratio: -	Dividend: -

Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 09.11.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 4.1 3 45

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $145.00 $275.90 $300.00 $320.00 -0.8%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 4 20 5 2 0

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current — — —

1 Mo Ago — — —

2 Mo Ago — — —

3 Mo Ago — — —

Most recent analyst action LATEST DESK ACTION

Date

8/10/2026

Firm

TD Cowen

Action

Boost Target

Rating

Buy

Target

$300.00

Full financial snapshot.

UPDATED 09.11.26

Quote snapshot 15 FIELDS

Prev Close

$273.00

Open

$276.01

Day Low

$275.63

Day High

$280.40

Bid

$262.23

Ask

$290.00

52W Low

$144.26

52W High

$303.31

50D Avg

$257.91

200D Avg

$201.88

Volume

767.6K

Avg Vol

895.9K

10D Avg Vol

762.8K

52W Change

78.56%

S&P 52W Change

15.30%

Valuation ratios 10 FIELDS

P/E (TTM)

—

P/E (Fwd)

21.93

PEG (Fwd)

0.12

P/S

3.32

P/B

4.68

Book Value

$59.50

EV/Revenue

4.04

EV/EBITDA

19.05

Mkt Cap

13.28B

Enterprise Val

16.18B

Profitability & returns 6 FIELDS

Profit Margin

-5.96%

Gross Margin

34.58%

Operating Margin

15.11%

EBITDA Margin

21.23%

Return on Assets

4.11%

Return on Equity

-7.52%

Growth 3 FIELDS

Revenue Growth (YoY)

-2.70%

Earnings Growth (YoY)

—

Earnings Growth (Q)

—

Balance sheet & cash flow 11 FIELDS

Total Revenue

EBITDA

849.12M

Total Cash

192.02M

Total Debt

3.03B

Cash / Share

$4.02

Revenue / Share

$81.86

Free Cash Flow

468.86M

Operating CF

582.15M

Debt / Equity

105.05

Current Ratio

1.35

Quick Ratio

0.80

Dividend 5 FIELDS

Fwd Dividend

—

Dividend Yield

—

Payout Ratio

0.00%

5Y Avg Yield

—

Ex-Div Date

—

Share statistics 7 FIELDS

Shares Out

47.74M

Float

47.22M

Shares Short

2.54M

% Short of Float

6.14%

Short Ratio

2.63

% Held Insiders

0.47%

% Held Institutions

123.09%

Calendar & events 5 FIELDS

Next Earnings

2026-11-04

Fiscal Year End

2025-12-27

Most Recent Qtr

2026-06-27

Last Split

—

Split Date

—

Company 2 FIELDS

Industry

Diagnostics & Research

Employees

18,300